These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 24055064)

  • 1. Pharmacokinetics.
    Fan J; de Lannoy IA
    Biochem Pharmacol; 2014 Jan; 87(1):93-120. PubMed ID: 24055064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PK/DB: database for pharmacokinetic properties and predictive in silico ADME models.
    Moda TL; Torres LG; Carrara AE; Andricopulo AD
    Bioinformatics; 2008 Oct; 24(19):2270-1. PubMed ID: 18684738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in Drug Discovery: An Exposure-Centred Approach to Optimising and Predicting Drug Efficacy and Safety.
    Reichel A; Lienau P
    Handb Exp Pharmacol; 2016; 232():235-60. PubMed ID: 26330260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput pKa screening and prediction amenable for ADME profiling.
    Wan H; Ulander J
    Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):139-55. PubMed ID: 16863474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Feb; 102(2):761-71. PubMed ID: 23233148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paediatric pharmacological principles: an update. Part 2. Pharmacokinetics: absorption and distribution.
    Kanneh A
    Paediatr Nurs; 2002 Nov; 14(9):39-43. PubMed ID: 12510334
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo rat PK profiling in drug discovery: new challenges.
    Zonzini L; Bianchi F; Cesari N; Sartori M
    Expert Opin Drug Discov; 2010 Nov; 5(11):1031-7. PubMed ID: 22827743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to drug pharmacokinetics in the critically ill patient.
    Smith BS; Yogaratnam D; Levasseur-Franklin KE; Forni A; Fong J
    Chest; 2012 May; 141(5):1327-1336. PubMed ID: 22553267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related aspects of pharmacokinetics (a review of the literature)].
    Bezverkhaia IS; Zapadniuk VI
    Farmakol Toksikol; 1980; 43(1):115-9. PubMed ID: 6991280
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and its role in small molecule drug discovery research.
    Jang GR; Harris RZ; Lau DT
    Med Res Rev; 2001 Sep; 21(5):382-96. PubMed ID: 11579439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and ADME characterizations of antibody-drug conjugates.
    Lin K; Tibbitts J; Shen BQ
    Methods Mol Biol; 2013; 1045():117-31. PubMed ID: 23913144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species differences in pharmacokinetics and pharmacodynamics.
    Toutain PL; Ferran A; Bousquet-Mélou A
    Handb Exp Pharmacol; 2010; (199):19-48. PubMed ID: 20204582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allometry Is a Reasonable Choice in Pediatric Drug Development.
    Liu T; Ghafoori P; Gobburu JV
    J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans.
    Fagerholm U
    Pharm Res; 2008 Mar; 25(3):625-38. PubMed ID: 17710514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination.
    Jones CR; Hatley OJ; Ungell AL; Hilgendorf C; Peters SA; Rostami-Hodjegan A
    AAPS J; 2016 May; 18(3):589-604. PubMed ID: 26964996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.